EFFECTS OF HYPERICUM EXTRACT HYP-811 IN PATIENTS WITH PSYCHOVEGETATIVE DISORDERS

The efficacy and tolerability of a 6-week course of Hypericum extract HYP 811 were investigated in a postmarketing surveillance study of 758 outpatients suffering from psychovegetative disorders. The investigat ions included a standardized list of typical somatic symptoms and glob al evaluations of the drug's efficacy and tolerability. By study end, 83.1% of patients had experienced a reduction in symptom severity, and the frequency of symptoms had improved by an average of 37.3%. After 3 weeks of treatment, the dosage could be reduced to one capsule per d ay in 35.8% of patients.